Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of nintedanib on lung functions and survival in idiopathic pulmonary fibrosis: real-life analysis of the Czech EMPIRE registry.
Štefániková M, Doubková M, Ovesná P, Šterclová M, Lacina L, Žurková M, Plačková M, Bartoš V, Janíčková I, Bittenglová R, Anton J, Sýkorová Ľ, Lošťáková V, Musilová P, Šuldová H, Mokošová R, Didyk J, Šišáková L, Lisá P, Lněnička J, Dařičková H, Doležel D, Pšikalová J, Tyl R, Králová R, Vašáková MK. Štefániková M, et al. Among authors: lacina l. BMC Pulm Med. 2023 May 3;23(1):154. doi: 10.1186/s12890-023-02450-3. BMC Pulm Med. 2023. PMID: 37138274 Free PMC article.
[Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry].
Doubková M, Uher M, Bartoš V, Šterclová M, Lacina L, Lošťáková V, Binková I, Plačková M, Žurková M, Bittenglová R, Pšikalová J, Šišková L, Lisá P, Petřík F, Polák J, Řihák V, Skřičková J, Vašáková M. Doubková M, et al. Among authors: lacina l. Cas Lek Cesk. 2016;155(4):22-8. Cas Lek Cesk. 2016. PMID: 27481198 Czech.
EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
Doubková M, Švancara J, Svoboda M, Šterclová M, Bartoš V, Plačková M, Lacina L, Žurková M, Binková I, Bittenglová R, Lošťáková V, Merta Z, Šišková L, Tyl R, Lisá P, Šuldová H, Petřík F, Pšikalová J, Řihák V, Snížek T, Reiterer P, Homolka J, Musilová P, Lněnička J, Palúch P, Hrdina R, Králová R, Hortvíková H, Strenková J, Vašáková M. Doubková M, et al. Among authors: lacina l. Clin Respir J. 2018 Apr;12(4):1526-1535. doi: 10.1111/crj.12700. Epub 2017 Sep 26. Clin Respir J. 2018. PMID: 28862397
Effect of pirfenidone on lung function decline and survival: 5-yr experience from a real-life IPF cohort from the Czech EMPIRE registry.
Zurkova M, Kriegova E, Kolek V, Lostakova V, Sterclova M, Bartos V, Doubkova M, Binkova I, Svoboda M, Strenkova J, Janotova M, Plackova M, Lacina L, Rihak V, Petrik F, Lisa P, Bittenglova R, Tyl R, Ondrejka G, Suldova H, Lnenicka J, Psikalova J, Snizek T, Homolka J, Kralova R, Kervitzer J, Vasakova M; ILD section; IPF registry. Zurkova M, et al. Among authors: lacina l. Respir Res. 2019 Jan 21;20(1):16. doi: 10.1186/s12931-019-0977-2. Respir Res. 2019. PMID: 30665416 Free PMC article.
The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis.
Tran T, Šterclová M, Mogulkoc N, Lewandowska K, Müller V, Hájková M, Kramer MR, Jovanović D, Tekavec-Trkanjec J, Studnicka M, Stoeva N, Hejduk K, Dušek L, Suissa S, Vašáková M; EMPIRE registry. Tran T, et al. Respir Res. 2020 Jan 8;21(1):11. doi: 10.1186/s12931-019-1271-z. Respir Res. 2020. PMID: 31915023 Free PMC article.
The Impact of Switching to a Second Antifibrotic in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective Multicentre Study From the EMPIRE Registry.
Gregor J, Adir Y, Šterclová M, Mogulkoc N, Kramer MR, Doubková M, Plačková M, Müller V, Studnicka M, Žurková M, Lacina L, Lewandowska K, Bartoš V, Ovesná P, Májek O, Koziar Vašáková M. Gregor J, et al. Among authors: lacina l. Arch Bronconeumol. 2024 Feb;60(2):80-87. doi: 10.1016/j.arbres.2023.12.002. Epub 2023 Dec 18. Arch Bronconeumol. 2024. PMID: 38160169 English, Spanish.
Small protein blockers of human IL-6 receptor alpha inhibit proliferation and migration of cancer cells.
Groza Y, Lacina L, Kuchař M, Rašková Kafková L, Zachová K, Janoušková O, Osička R, Černý J, Petroková H, Mierzwicka JM, Panova N, Kosztyu P, Sloupenská K, Malý J, Škarda J, Raška M, Smetana K Jr, Malý P. Groza Y, et al. Among authors: lacina l. Cell Commun Signal. 2024 May 7;22(1):261. doi: 10.1186/s12964-024-01630-w. Cell Commun Signal. 2024. PMID: 38715108 Free PMC article.
Unravelling heterogeneous effects of cancer‑associated fibroblasts on poor prognosis markers in breast cancer EM‑G3 cell line: In vitro‑targeted treatment (anti‑IL-6, anti‑VEGF-A, anti‑MFGE8) based on transcriptomic profiling.
Urban L, Novák Š, Čoma M, Dvořánková B, Lacina L, Šáchová J, Hradilová M, Svatoňová P, Kolář M, Strnad H, Březinová J, Smetana K Jr, Gál P, Szabo P. Urban L, et al. Among authors: lacina l. Oncol Rep. 2024 Jan;51(1):3. doi: 10.3892/or.2023.8662. Epub 2023 Nov 17. Oncol Rep. 2024. PMID: 37975220 Free PMC article.
81 results